Irene Franklin

Irene Franklin, PharmD, is an accomplished leader in pharmacovigilance and drug safety with extensive experience across multiple organizations. Currently serving as Executive Director of Pharmacovigilance at CTI BioPharma since June 2022, Irene also holds a consulting role as Senior Director of Pharmacovigilance at Braeburn. Previous positions include Senior Director of Pharmacovigilance at Checkmate Pharmaceuticals, and Executive Director of Pharmacovigilance and Medical Information at Cormedix Inc., where responsibilities included establishing pharmacovigilance units, overseeing compliance, and managing third-party collaborations. Irene's career includes key roles at PTC Therapeutics, Leadiant Biosciences, Enzon Pharmaceuticals, and Schering-Plough Research Institute, emphasizing expertise in regulatory compliance, signal evaluation, SOP development, and data management in drug safety. Irene earned a PharmD from The University of Kansas and a BS in Pharmacy from Long Island University.